MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mulcahy, L. S.
Right arrow Articles by Gans, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mulcahy, L. S.
Right arrow Articles by Gans, J. H.

The fidelity of mouse liver mitochondrial DNA polymerase following long- term administration of carbon tetrachloride, diethylnitrosamine, or phenobarbital

LS Mulcahy and JH Gans

The fidelity of liver mtDNA polymerase was compared in control mice, in mice treated chronically with diethylnitrosamine (DEN), carbon tetrachloride (CCl4), or phenobarbital sodium (PBNa). Liver mitochondria were isolated, and the mtDNA polymerase activity was obtained by high-salt extraction and subjected to chromatography first on DEAE-cellulose (DE 52) and then on heparin-Sepharose. Fidelity of the mtDNA polymerase was determined, after heparin-Sepharose chromatography, by measuring the relative incorporation of a complementary nucleotide, [32P]dTMP, and a noncomplementary nucleotide, [3H]dGMP, into acid-precipitable material with enzyme activity directed by the template-primer poly(A) . oligo(dT) 12-18. A decrease in fidelity (increase in relative incorporation [3H]dGMP) was observed after 12 or 13 weeks of treatment with DEN. The fidelity of mouse liver mtDNA polymerase also was decreased after 12 weeks of treatment with PBNa. By contrast, treatment for 12 weeks with CCl4 was accompanied either by increased fidelity (decrease in the relative incorporation of [3H]dGMP) or no change in fidelity.

Volume 24, Issue 2, pp. 329-335, 09/01/1983
Copyright © 1983 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1983 by the American Society for Pharmacology and Experimental Therapeutics